Subo, Joji R.
HRN: 15-22-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/06/2022
CEFUROXIME 1.5GM (VIAL)
08/06/2022
08/07/2022
IV
1.5 Gms X 3 Doses
Q8 X 3 Doses
LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes